Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bc8 (2 trials)
cyclosporine (sandimmune) (1 trial)
fludarabine (fludara) (1 trial)
hemopoietic stem cell (1 trial)
mycophenolate (CellCept) (1 trial)
tacrolimus (prograf) (1 trial)
azacitidine (vidaza) (1 trial)
cytarabine (cytosar-u) (1 trial)
furosemide (lasix) (1 trial)
lintuzumab (5 trials)
spironolactone (aldactone) (2 trials)
venetoclax (venclexta) (2 trials)
19-28z t cells (1 trial)
Acute Disease (Phase 3)
Leukemia (Phase 3)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Multiple Myeloma (Phase 1)
Myelodysplastic Syndromes (Phase 1)
Neoplasms, Plasma Cell (Phase 1)
Trials (7 total)
Trial APIs (13 total)